Arbutus Biopharma
ABUS
#7158
Rank
โ‚น59.07 B
Marketcap
โ‚น385.40
Share price
1.49%
Change (1 day)
-4.23%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2026 (TTM): โ‚น14.35 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are โ‚น0.18 Billion. In 2025 the company made an earning of -โ‚น3.16 Billion, an increase over its 2024 earnings that were of -โ‚น6.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น14.35 B-554.6%
2025 -โ‚น3.16 Billion-52.09%
2024 -โ‚น6.59 Billion-4.02%
2023 -โ‚น6.87 Billion12.05%
2022 -โ‚น6.13 Billion-14.74%
2021 -โ‚น7.19 Billion19.61%
2020 -โ‚น6.01 Billion-61.69%
2019 -โ‚น15.68 Billion171.23%
2018 -โ‚น5.79 Billion-43.58%
2017 -โ‚น10.25 Billion-77.77%
2016 -โ‚น46.1 Billion532.77%
2015 -โ‚น7.29 Billion99.05%
2014 -โ‚น3.66 Billion175.82%
2013 -โ‚น1.33 Billion-143.7%
2012 โ‚น3.03 B-399.11%
2011 -โ‚น1.02 Billion-39.03%
2010 -โ‚น1.67 Billion100.55%
2009 -โ‚น0.84 Billion-28.56%
2008 -โ‚น1.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-101.41% Bahamas
NRC Health
NRC
โ‚น1.39 B-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA